Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3057% above fair value
$3.80−0.29 (-7.09%)
Close on Nov 13, 2026Market cap $238.46MP/E –Yield 0.00%
Camp4 Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Camp4 Therapeutics's price to sales ratio was 51.7× on Nov 11, 2026, against 46.9× a year earlier. Over the last 2 years it ranged from 0.5× to 151.7×, with a median of 46.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 51.7× | −23.9 |
| 2025 | Dec 31, 2025 | 75.6× | +61.6 |
| 2024 | Oct 31, 2024 | 14.0× | – |
See a number that looks wrong?